
1.42 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 0.88 Today|||52-Week Range 5.75 | -2.74% Year-to-Date |
Insider Sell: CFO and COO Daniel Chevallard Sells 3,635 Shares of Viracta Therapeutics Inc (VIRX) May 28 / GuruFocus News - Paid Partner Content | Insider Sell: CFO and COO Daniel Chevallard Sells 3,635 Shares of Viracta Therapeutics Inc (VIRX) May 27 / GuruFocus News - Paid Partner Content |
Previous close | 1.33 |
Today’s open | 1.35 |
Day’s range | 1.32 - 1.43 |
Volume | 4,478 |
Average volume (3 months) | 166,199 |
Market cap | $56.1M |
Earnings growth (last year) | +63.85% |
Earnings growth (this year) | +10.00% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -- |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 1.01 |
Today’s change | Today’s % change | |
---|---|---|
MEIPMEI Pharma Inc | -0.20 | -2.60% |
ASMBAssembly Biosciences... | +0.00 | +0.44% |
MBIOMustang Bio Inc | -0.22 | -3.44% |
EIGREiger BioPharmaceuti... | 0.00 | 0.00% |
Next reporting date | August 9, 2023 |
EPS forecast (this quarter) | -$0.29 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$49.2M |
Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cardiff, California |